Home LiteratureArticle Details
PMID: 8249026 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system.

Stroke ·Vol. 24 ·No. 12 Suppl ·1993-12-00 ·Pages I84-90

Giulian D, Vaca K

Abstract

Reactive microglia respond within hours to central nervous system ischemic injury as exhibited by increased surface molecules, including the scavenger receptor. It is at least several days after an insult, however, before these activated mononuclear phagocytes reach a peak of secretory activity with the release of neurotoxins. This period of cytotoxin secretion is associated with a delayed neuronal loss seen in tissues neighboring sites of ischemia. Microglia-suppressing drugs reduce tissue production of neurotoxic factors and improve functional outcome after ischemic injury. Immunosuppressive therapy may offer a means to reduce late neuronal damage associated with stroke.

MeSH Terms
Animals Central Nervous System/blood supply Central Nervous System Diseases/etiology,pathology,physiopathology Inflammation/etiology,pathology,physiopathology Ischemia/complications,metabolism,pathology Microglia/metabolism,physiology Neurons/pathology Neurotoxins/metabolism Phagocytes/metabolism Rabbits Rats Time Factors
Chemicals
Neurotoxins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Giulian D
Department of Neurology, Baylor College of Medicine, Houston, TX 77030.
Vaca K
Article Info
Journal
Stroke
Abbr.
Stroke
ISSN
0039-2499
Published
1993-12-00
Pages
I84-90
Language
English
Region
United States
NLM ID
0235266
Subset
IM
Grants
NINDS NIH HHS · NS-23115 · United States
NINDS NIH HHS · NS-25637 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com